Too Old to Operate16h
SUMMIT: Tirzepatide Reduces Cardiovascular Events in HFpEF Plus Obesity
In the phase 3 SUMMIT trial, tirzepatide, was found to reduce the risk for worsening heart failure in patients with preserved ...
Too Old to Operate16h
ENBALV: Edoxaban or Warfarin as Anticoagulant After Bioprosthetic Valve Replacement?
In the ENBALV study, it was inconclusive whether edoxaban is a better treatment than warfarin for patients with early ...
Too Old to Operate15h
Interventions Are Needed in MS to Improve Early Treatment Accessibility
An analysis of more than 5,300 patients with MS shows that access to early treatment in MS varies, though those with ...